Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05157100 · ClinicalTrials.gov registry record · Phase 4
Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia
A Phase 4 study of Cervical Dystonia, sponsored by The Orthopedic Foundation.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05157100: Completed Phase 4 study of Cervical Dystonia, sponsored by The Orthopedic Foundation.
NCT05157100 is a Phase 4 study of Cervical Dystonia that has completed, run by The Orthopedic Foundation. The registered enrollment target is 20 participants, below the 86-participant average among 15 other Cervical Dystonia trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05157100, a Phase 4 study of Cervical Dystonia, has completed, sponsored by The Orthopedic Foundation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Study of Ingrezza (Valbenazine) for the treatment of cervical dystonia.
Primary Outcome
Change in incidence rate of pain/spasm as measured by frequency and intensity in subjects prior to and during use of valbenazine as measured by Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) and Inertial measurement unit (IMU). TWSTRS is a composite scale used to measure three aspects of CD: severity, disability, and pain. TWSTRS total score falls within the range of 0 to 85, where a higher score indicates a more severe condition.
Conditions Studied
Interventions
- DRUG Ingrezza Pill
Study Locations (1)
Ohio
- The Orthopedic foundation - New Albany
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-10-19 |
| Est. Completion | 2023-09-15 |
| Phase | Phase 4 |
What the finished NCT05157100 record still lists
NCT05157100 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 86-participant average among 15 other Cervical Dystonia trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Cervical Dystonia appearing as the primary indexed condition, and to 1 intervention - of which Ingrezza Pill is the first listed.
NCT05157100 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05157100 about?
NCT05157100 is a clinical study titled "Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia". Study of Ingrezza (Valbenazine) for the treatment of cervical dystonia.
What is the current status of trial NCT05157100?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2021-10-19. Estimated completion is 2023-09-15.
What conditions does trial NCT05157100 study?
This clinical trial studies the following conditions: Cervical Dystonia.
What interventions are being tested in trial NCT05157100?
The interventions under investigation include: Ingrezza Pill (DRUG).
Who is sponsoring clinical trial NCT05157100?
This trial is sponsored by The Orthopedic Foundation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05157100 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Dystonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05157100's enrollment target sits among peer trials
20 13th of 15 the lowest of 15 other Cervical Dystonia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cervical Dystonia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
RECRUITING · Phase 2
-
Safety and Effectiveness of Valbenazine as Adjunct Therapy to Botulinum Toxin Injections in Cervical Dystonia
RECRUITING · Phase 2
-
Effect of Vibro-tactile Stimulation Intensity on Head Posture in Cervical Dystonia
RECRUITING · NA
-
Zinc as an Adjunctive Therapy for Cervical Dystonia
RECRUITING · Phase 2
-
Deep Brain Stimulation to Treat Cervical Dystonia
COMPLETED · Phase 1
-
Safety and Tolerability of Perampanel in Cervical Dystonia
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI